214 related articles for article (PubMed ID: 19477351)
1. Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone).
Lonn EM; Gerstein HC; Sheridan P; Smith S; Diaz R; Mohan V; Bosch J; Yusuf S; Dagenais GR;
J Am Coll Cardiol; 2009 Jun; 53(22):2028-35. PubMed ID: 19477351
[TBL] [Abstract][Full Text] [Related]
2. Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.
; Dagenais GR; Gerstein HC; Holman R; Budaj A; Escalante A; Hedner T; Keltai M; Lonn E; McFarlane S; McQueen M; Teo K; Sheridan P; Bosch J; Pogue J; Yusuf S
Diabetes Care; 2008 May; 31(5):1007-14. PubMed ID: 18268075
[TBL] [Abstract][Full Text] [Related]
3. STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone): is the biggest big enough?
Kaski JC; Cockerill GW
J Am Coll Cardiol; 2009 Jun; 53(22):2036-8. PubMed ID: 19477352
[No Abstract] [Full Text] [Related]
4. [DREAM study: prevention of type 2 diabetes with ramipril and/or rosiglitazone in persons with dysglycaemia but no cardiovascular desease].
Scheen AJ
Rev Med Liege; 2006 Oct; 61(10):728-32. PubMed ID: 17209507
[TBL] [Abstract][Full Text] [Related]
5. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.
Crouse JR; Raichlen JS; Riley WA; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Bots ML;
JAMA; 2007 Mar; 297(12):1344-53. PubMed ID: 17384434
[TBL] [Abstract][Full Text] [Related]
6. Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial.
Mazzone T; Meyer PM; Feinstein SB; Davidson MH; Kondos GT; D'Agostino RB; Perez A; Provost JC; Haffner SM
JAMA; 2006 Dec; 296(21):2572-81. PubMed ID: 17101640
[TBL] [Abstract][Full Text] [Related]
7. Searching for the right outcome? A systematic review and meta-analysis of controlled trials using carotid intima-media thickness or pulse wave velocity to infer antiatherogenic properties of thiazolidinediones.
Webb DR; Davies MJ; Gray LJ; Abrams KR; Srinivasan B; Das S; Taub N; Lawrence I; Sutton S; Khunti K
Diabetes Obes Metab; 2010 Feb; 12(2):124-32. PubMed ID: 19922476
[TBL] [Abstract][Full Text] [Related]
8. Effect of rosiglitazone/ramipril on preclinical vasculopathy in newly diagnosed, untreated diabetes and IGT patients: 1-year randomised, double-blind, placebo-controlled study.
Rahman S; Ismail AA; Ismail SB; Naing NN; Abdul Rahman AR
Eur J Clin Pharmacol; 2007 Aug; 63(8):733-41. PubMed ID: 17565489
[TBL] [Abstract][Full Text] [Related]
9. Does baseline carotid intima-media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima-media thickness progression? The METEOR study.
Crouse JR; Bots ML; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Raichlen JS;
Eur J Cardiovasc Prev Rehabil; 2010 Apr; 17(2):223-9. PubMed ID: 20038840
[TBL] [Abstract][Full Text] [Related]
10. Effect of Rosiglitazone and Ramipril on {beta}-cell function in people with impaired glucose tolerance or impaired fasting glucose: the DREAM trial.
Hanley AJ; Zinman B; Sheridan P; Yusuf S; Gerstein HC;
Diabetes Care; 2010 Mar; 33(3):608-13. PubMed ID: 20009095
[TBL] [Abstract][Full Text] [Related]
11. Hyperglycaemia after glucose loading is a major predictor of preclinical atherosclerosis in nondiabetic subjects.
Zhang YF; Hong J; Zhan WW; Li XY; Gu WQ; Yang YS; Xu M; Ning G
Clin Endocrinol (Oxf); 2006 Feb; 64(2):153-7. PubMed ID: 16430713
[TBL] [Abstract][Full Text] [Related]
12. Modifying the natural history of atherosclerosis: the SECURE trial.
Lonn E
Int J Clin Pract Suppl; 2001 Jan; (117):13-8. PubMed ID: 11715353
[TBL] [Abstract][Full Text] [Related]
13. Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance.
Hanefeld M; Chiasson JL; Koehler C; Henkel E; Schaper F; Temelkova-Kurktschiev T
Stroke; 2004 May; 35(5):1073-8. PubMed ID: 15073402
[TBL] [Abstract][Full Text] [Related]
14. Effect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: the glucose reduction and atherosclerosis continuing evaluation study (ORIGIN-GRACE).
Lonn EM; Bosch J; Diaz R; Lopez-Jaramillo P; Ramachandran A; Hâncu N; Hanefeld M; Krum H; Ryden L; Smith S; McQueen MJ; Dyal L; Yusuf S; Gerstein HC;
Diabetes Care; 2013 Sep; 36(9):2466-74. PubMed ID: 23564916
[TBL] [Abstract][Full Text] [Related]
15. [Influence of diabetes incidence by ramipril and rosiglitazone: DREAM study (diabetes reduction assessment with ramipril and rosiglitazone medication)].
Standl E; Nitschmann S
Internist (Berl); 2007 Oct; 48(10):1173-6. PubMed ID: 17846732
[No Abstract] [Full Text] [Related]
16. Effect of antihypertensive therapy on progression of carotid intima-media thickness in patients with type 2 diabetes mellitus.
Zheng L; Hodis HN; Buchanan TA; Li Y; Mack WJ
Am J Cardiol; 2007 Apr; 99(7):956-60. PubMed ID: 17398191
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone and carotid IMT progression rate in a mixed cohort of patients with type 2 diabetes and the insulin resistance syndrome: main results from the Rosiglitazone Atherosclerosis Study.
Hedblad B; Zambanini A; Nilsson P; Janzon L; Berglund G
J Intern Med; 2007 Mar; 261(3):293-305. PubMed ID: 17305652
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes.
Stocker DJ; Taylor AJ; Langley RW; Jezior MR; Vigersky RA
Am Heart J; 2007 Mar; 153(3):445.e1-6. PubMed ID: 17307426
[TBL] [Abstract][Full Text] [Related]
19. Effect of ramipril on the incidence of diabetes.
; Bosch J; Yusuf S; Gerstein HC; Pogue J; Sheridan P; Dagenais G; Diaz R; Avezum A; Lanas F; Probstfield J; Fodor G; Holman RR
N Engl J Med; 2006 Oct; 355(15):1551-62. PubMed ID: 16980380
[TBL] [Abstract][Full Text] [Related]
20. Heart-type fatty acid binding protein (H-FABP): relationship with arterial intima-media thickness and role as diagnostic marker for atherosclerosis in patients with ımpaired glucose metabolism.
Karbek B; Özbek M; Bozkurt NC; Ginis Z; Güngünes A; Ünsal IÖ; Cakal E; Delibası T
Cardiovasc Diabetol; 2011 May; 10():37. PubMed ID: 21535886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
